Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Joseph C. Fratantoni"'
Autor:
Madhusudan V. Peshwa, Cornell Allen, Stephanie Feller, Sergey Dzekunov, Hiroyuki Fujisaki, Lawrence A. Wolfraim, Linhong Li, Joseph C. Fratantoni, Linda N. Liu, Dario Campana, Rama Shivakumar, Nicholas Chopas
Publikováno v:
Cancer Gene Therapy. 17:147-154
Natural killer (NK) cells hold promise for cancer therapy. NK cytotoxicity can be enhanced by expression of chimeric antigen receptors that re-direct specificity toward target cells by engaging cell surface molecules expressed on target cells. We dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaf5246325fbae117ebcb5b88b9212f2
https://doi.org/10.1038/cgt.2009.61
https://doi.org/10.1038/cgt.2009.61
Publikováno v:
BioProcessing Journal. 3:49-53
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fec738d3e03570f44046380d075330f8
https://doi.org/10.12665/j36.fratantoni
https://doi.org/10.12665/j36.fratantoni
Autor:
Linhong Li, William E. Fogler, Stephanie Feller, Joseph C. Fratantoni, Linda N. Liu, Jonathan M. Weiss, Rama Shivakumar, Art D. Hanson
Publikováno v:
Cancer Gene Therapy. 11:346-353
Using a nonviral, electroporation-based gene transfection approach, we demonstrate the efficient and consistent transfection of two poorly immunogenic tumor cell lines: B16F10 melanoma and renal carcinoma (RENCA). Three genes, IL-12, angiostatin (AS)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c04cbb4538a64eecc4c1a4a5d49f6513
https://doi.org/10.1038/sj.cgt.7700686
https://doi.org/10.1038/sj.cgt.7700686
Publikováno v:
Transfusion. 36:770-775
Background The pooling of human plasma from many donors for the purpose of manufacturing therapeutic proteins increases the risk of exposing recipients of these proteins to pathogens that may contaminate 1 or a few units included in the pool. Study d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd2068571f15fbc55600fe421777aafc
https://doi.org/10.1046/j.1537-2995.1996.36996420751.x
https://doi.org/10.1046/j.1537-2995.1996.36996420751.x
Autor:
Rama Shivakumar, Stephanie Feller, Linhong Li, John W. Holaday, Cornell Allen, Sergey Dzekunov, Linda N. Liu, Joseph C. Fratantoni, Jonathan M. Weiss, Vin Singh
Publikováno v:
Technology in Cancer Research & Treatment. 1:341-349
Electroporation is widely used to transfect and load cells with various molecules. Traditional electroporation using a static mode is typically restricted to volumes less than 1 mL, which limits its use in clinical and industrial bioprocessing applic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::921e0aaffc917cd559b74b7c59d6f0fc
https://doi.org/10.1177/153303460200100504
https://doi.org/10.1177/153303460200100504
Publikováno v:
Transfusion. 37:866-876
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc44ec3b549215e33a7a88d3b0b421be
https://doi.org/10.1046/j.1537-2995.1997.37897424413.x
https://doi.org/10.1046/j.1537-2995.1997.37897424413.x
Publikováno v:
Transfusion. 35:783-790
The 2-day conference clearly outlined the formulations of products that are being developed or are commercially available in Europe. The major difference between products in the United States and those in Europe is that US manufacturers are preparing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0eb5ebef7f2a4791c021e011a9aced35
https://doi.org/10.1046/j.1537-2995.1995.35996029166.x
https://doi.org/10.1046/j.1537-2995.1995.35996029166.x
Autor:
Martha P. Mims, Eric Yvon, Linhong Li, Madhusudan V. Peshwa, Gianpietro Dotti, George Carrum, Joseph C. Fratantoni, Helen E. Heslop, Fatma V Okur, Ettore Biagi, Malcolm K. Brenner
Background aims. Several studies have demonstrated that the immunogenicity of chronic lymphocytic leukemia (CLL) cells can be increased by manipulation of the CD40/CD40-ligand (CD40L) pathway. Although immunologic, and perhaps clinical, benefits have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c949c43624c31c1546636bed0c234f99
http://hdl.handle.net/10281/25433
http://hdl.handle.net/10281/25433
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 423
Results from multiple human studies have continued to spur the development of dendritic cells (DCs) as therapeutic vaccines for the treatment of cancer, chronic viral infections, and autoimmune diseases. The antigen-specific activity of DCs is depend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cdeb3f8d8642c1d29a96e4a0d98bc5a6
https://pubmed.ncbi.nlm.nih.gov/18370195
https://pubmed.ncbi.nlm.nih.gov/18370195